Viral hepatitis B in patients with hematological malignancies (Overview)
نویسندگان
چکیده
The review presents current data on the role of viral hepatitis B in oncohematological patients. Possible ways infection, prevention and activation this category patients are considered. specific features course various clinical situations described: against background other infections conduct anti-leukemia therapy.
منابع مشابه
Viral infections in patients with hematological malignancies.
Viral infections remain one of the most frequent complications in patients with hematological malignancies, especially in those receiving an allogeneic stem cell transplantation. Viral infections result from reactivation of latent infection rather than from acquisition of new infection. Infections caused by herpes viruses, including cytomegalovirus and Epstein-Barr virus, respiratory viruses an...
متن کاملViral Infections in Patients with Hematological Malignancies
Correspondence: James C. Wade, MD, MPH, Medical College of Wisconsin, 9200 W. WI Ave., FEC 3963A, Milwaukee WI 53226; Phone 414-805-4609; Fax 414-805-4606; Email: [email protected] Viral infections are important causes of morbidity and mortality for patients with a hematological malignancy. However, the true incidence and consequences of viral infections for these patients who undergo conventional ...
متن کاملHepatitis B Reactivation in Patients with Hematological Malignancies and Stem Cell Transplantation
Hepatitis B infection is the leading cause of chronic hepatitis, cirrhosis and hepatocellular carcinoma and is thought to be responsible for million deaths per year globally. Management of patients with resolved or active hepatitis B and cancer is a challenge and these patients are at higher risk of hepatitis B related complications due to immunosuppression and loss of prior immunity. The treat...
متن کاملProspective study of hepatitis B virus reactivation in patients with hematological malignancies.
BACKGROUND AND AIM The best strategy for managing patients with resolved hepatitis B virus infection (HBsAg negative, anti-HBc antibodies positive with or without anti-HBs antibodies) and hematological malignancies under immunosuppressive therapies has not been defined. The aim of this study was to prospectively analyze the risk of hepatitis B virus reactivation in these patients. MATERIAL AN...
متن کاملImmunogenicity of the Cuban anti-hepatitis B recombinant DNA vaccine in patients with Hematological Malignancies
Parenteral-transmitted viral hepatitis is a significant health problem in persons with hematological malignancies that is why prevention measures against them are needed. One of the most important interventions is the prophylactic vaccination against hepatitis B virus infection. The results of a clinical trial using the Cuban antihepatitis B recombinant DNA vaccine in a group of adult patients ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Archives of hepatitis research
سال: 2023
ISSN: ['2641-2977']
DOI: https://doi.org/10.17352/ahr.000034